A novel antigenic site spanning domains I and III of the Zika virus envelope glycoprotein is the target of strongly neutralizing human monoclonal antibodies
S. Graham, H. A. Tu, B. D. McElvany, N. R. Graham, A. Grinyo, E. Davidson, B. J. Doranz, S. A. Diehl, A. M. de Silva, A. J. Markmann
This study identifies a novel antigenic site on the Zika virus envelope glycoprotein targeted by a strongly neutralizing human monoclonal antibody, providing insights for vaccine design.
bioRxiv · Dec 21, 2020Immunology